The French Biosimilars market

French health authorities intent – cautiously – to facilitate the development of the biosimilars market by:

  • Encouraging with incentives the prescription of physicians.
  • Expending the number of substitutable biologic drugs by retail pharmacists.

This new publication analyses the current and future situations of the hospital and retail market segments.

For so doing, Smart Pharma consultants have capitalized on their strong market insights.